Meningitis Literature

Abad R, Medina V, del Carmen Farinas M, et al. Potential impact of the 4CMenB vaccine on oropharyngeal carriage of Neisseria meningitides. J Infect 2017 (published online Oct 5)

Alemayehu T, Mekasha A, Abebe T. Nasal carriage rate and antibiotic susceptibility pattern of Neisseria meningitidis in healthy Ethiopian children and adolescents: a cross-sectional study. PLoS One 2017 Oct 26;12(10):e0187207

Balada-Llasat JM, Rosenthal N, Hasbun R, et al. Cost of managing meningitis and encephalitis among adult patients in the United States. Int J Infect Dis 2018 (published online Apr 24)

Basta NE, Berthe A, Keita M, et al. Meningococcal carriage within households in the African meningitis belt: a longitudinal pilot study. J Infect 2017 (published online Nov 29)

Beeslaar J, Absalon J, Balmer P, et al. Clinical data supporting a 2-dose schedule of MenB-FHbp, a bivalent meningococcal serogroup B vaccine, in adolescents and young adults. Vaccine 2018 (published online Jun 1)

Bloch D, Murray K, Peterson E, et al. Sex difference in meningococcal disease mortality, New York City, 2008-2016. Clin Infect Dis 2018 (published online Mar 2)

Breakwell L, Whaley M, Khan UI, et al. Meningococcal carriage among a university student population — United States, 2015. Vaccine 2017 (published online Nov 26)

Chen P, Lin X, Liu G, et al. Analysis of enterovirus types in patients with symptoms of aseptic meningitis in 2014 in Shandong, China. Virology 2018 March;516:196-201

Davizon ES, Soeters HM, Miller L, et al. Two cases of meningococcal disease in one family separated by an extended period — Colorado, 2015-2016. MMWR 2018 Mar 30;67(12):366-8

Dbaibo G, Favila JCT, Traskine M, et al. Immunogenicity and safety of MenACWY-TT, a meningococcal conjugate vaccine, co-administered with routine childhood vaccine in healthy infants: a phase III, randomized study. Vaccine 2018 (published online May 18)

Fiorito TM, Baird GL, Alexander-Scott N, et al. Adverse events following vaccination with bivalent rLP2086 (Trumenba): an observational, longitudinal study during a college outbreak and a systematic review. Pediatr Infect Dis J 2018 Jan 37(1):e13-9

Flacco ME, Manzoli L, Rosso A, et al. Immunogenicity and safety of the multicomponent meningococcal B vaccine (4CMenB) in children and adolescents: a systematic review and meta-analysis. Lancet Infect Dis 2018 (published online Jan 19)

Guiddir T, Gros M, Hong E, et al. Unusual initial abdominal presentations of invasive meningococcal disease. Clin Infect Dis 2018 (published online Mar 28)

Hansen J, Zhang L, Klein NP, et al. Post-licensure safety surveillance study of routine use of quadrivalent meningococcal diphtheria toxoid conjugate vaccine. Vaccine 2017 (published online Sep 21)

Hassan A, Mustapha GU, Lawal BB, et al. Time delays in the response to the Neisseria meningitides serogroup C outbreak in Nigeria – 2017. PLoS One 2018 Jun 19;13(6):e0199257

Knol MJ, Ruijs WLM, Antonise-Kamp L, et al. Implementation of MenACWY vaccination because of ongoing increase in serogroup W invasive meningococcal disease, the Netherlands, 2018. Euro Surveill 2018 Apr 19;23(16):pii=18-00158

Li J, Shao Z, Liu G, et al. Meningococcal disease and control in China: findings and updates from the Global Meningococcal Initiative (GMI). J Infect 2018 (published online Feb 1)

MacNeil JR, Blain AE, Wang X, et al. Current epidemiology and trends in meningococcal disease — United States, 1996-2015. Clin Infect Dis 2017 (published online Nov 8)

Mandal S, Campbell H, Ribeiro S, et al. Risk of invasive meningococcal disease in university students in England and optimal strategies for protection using MenACWY vaccine. Vaccine 2017 (published online Sep 18)

Martinon-Torres F, Martinez AC, Simko R, et al. Antibody persistence and booster responses 24-36 months after different 4CMenB vaccination schedules in infants and children: a randomised trial. J Infect 2017 (published online Dec 15)

McGill F, Griffiths MJ, Bonnett LJ, et al. Incidence, aetiology, and sequelae of viral meningitis in UK adults: a multicentre prospective observational cohort study. Lancet Infect Dis 2018 (published online Jun 2018)

McNamara LA, Thomas JD, MacNeil J, et al. Meningococcal carriage following a university serogroup B meningococcal disease outbreak and vaccination campaign with MenB-4C and MenB-FHbp — Oregon, 2015-2016. J Infect Dis 2017 (published online Aug 26)

Mentzer D, Oberle D, Keller-Stanislawski B. Adverse events following immunisation with a meningococcal serogroup B vaccine: report from post-marketing surveillance, Germany, 2013 to 2016. Euro Surveill 2018 Apr 26;23(17):pii=17-00468

Molloy SF, Kanyama C, Heyderman RS, et al. Antifungal combinations for treatment of cryptococcal meningitis in Africa. N Engl J Med 2018 Mar 15;378(11):1004-17

Moura ARSS, Kretz CB, Ferreira IE, et al. Molecular characterization of Neisseria meningitides isolates recovered from 11-19-year-old meningococcal carriers in Salvador, Brazil. PLoS One 2017 Sep 20;12(9):e0185038

Mowlaboccus S, Mullally CA, Richmond PC, et al. Differences in population structure of Neisseria meningitides in two Australian states: Victoria and Western Australia. PLoS One 2017 Oct 24;12(10):e0186839

Nnadi C, Oladejo J, Yennan S, et al. Large outbreak of Neisseria meningitides serogroup C — Nigeria, December 2016-June 2017. MMWR 2017 Dec 15;66(49):1352-6

Oldfield NJ, Green LR, Parkhill J, et al. Limited impact of adolescent meningococcal ACWY vaccination on group W carriage in university students. J Infect Dis 2017 (published online Nov 15)

Oordt-Speets AM, Bolijn R, van Hoorn RC, et al. Global etiology of bacterial meningitis: a systematic review and meta-analysis. PLoS One 2018 Jun 11;13(6):e0198772

Ostergaard L, Vesikari T, Absalon J, et al.A bivalent meningococcal B vaccine in adolescents and young adults. N Engl J Med 2017 Dec 14;377(24):2349-62

Ouldali N, Levy C, Varon E, et al. Incidence of paediatric pneumococcal meningitis and emergence of new serotypes: a time-series analysis of a 16-year French national survey. Lancet Infect Dis 2018 (published online Jul 23)

Patel JC, George J, Vuong J, et al. Rapid laboratory identification of Neisseria meningitidis serogroup C as the cause of an outbreak — Liberia, 2017. MMWR 2017 Oct 27;66(42):1144-7

Peterson ME, Mile R, Li Y, et al. Meningococcal carriage in high-risk settings: a systematic review. Int J Infect Dis 2018 (published online Jul 8)

Pirez MC, Mota MI, Giachetto G, et al. Pneumococcal meningitis before and after universal vaccination with pneumococcal conjugate vaccines 7/13, impact on pediatric hospitalization in public and nonpublic institutions, in Uruguay. Pediatr Infect Dis J 2017 Oct;36(10):1000-1

Regev-Yochay G, Reisenberg K, Katzir M, et al. Pneumococcal meningitis in adults after introduction of PCV7 and PCV13, Israel, July 2009-June 2015. Emerg Infect Dis 2018 (published online May 30)

Regev-Yochay G, Reisenberg K, Katzir M, et al. Pneumococcal meningitis in adults after introduction of PCV7 and PCV13, Israel, July 2009-June 2015. Emerg Infect Dis 2018 (published online May 30)

Rivera L, Chanthavanich P, Poder A, et al. MenACWY-TT is immunogenic when co-administered with Tdap and AS04-HPV16/18 in girls and young women: results from a phase III randomized trial. Vaccine 2018 (published online May 19)

Rodrigues CMC, Lucidarme J, Borrow R, et al. Genomic surveillance of 4CMenB vaccine antigenic variants among disease-causing Neisseria meningitidis isolates, United Kingdom, 2010-2016. Emerg Infect Dis 2018 (published online Feb 27)

Romain AS, Cohen R, Plainvert C, et al. Clinical and laboratory features of Group B Streptococcus meningitis in infants and newborns: study of 848 cases in France from 2001-2014. Clin Infect Dis 2017 (published online Oct 16)

Thabuis A, Tararbit K, Taha MK, et al. Community outbreak of serogroup B invasive meningococcal disease in Beaujolais, France, February to June 2016: from alert to targeted vaccination. Euro Surveill 2018 Jul 12;23(28):pii=1700590

Thomson J, Cruz AT, Nigrovic LE, et al. Concomitant bacterial meningitis in infants with urinary tract infection. Pediatr Infect Dis J 2017 Sep;36(9):908-10

Yaro S, Lafourcade BMN, Ouangraoua S, et al. Antibody persistence at the population level 56 years after mass vaccination with meningococcal serogroup A conjugate vaccine (PsA-TT) in Burkina Faso: need for a booster campaign? Clin Infect Dis 2018 (published online Jul 26)

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead Become an underwriter»